These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 32439219)
1. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT. Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219 [TBL] [Abstract][Full Text] [Related]
2. Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling. Fullerton PT; Creighton CJ; Matzuk MM Mol Endocrinol; 2015 Oct; 29(10):1440-53. PubMed ID: 26284758 [TBL] [Abstract][Full Text] [Related]
3. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis. Yasutome M; Gunn J; Korc M Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109 [TBL] [Abstract][Full Text] [Related]
5. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743 [TBL] [Abstract][Full Text] [Related]
6. Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells. Le Gendre O; Sookdeo A; Duliepre SA; Utter M; Frias M; Foster DA Mol Cancer Res; 2013 May; 11(5):474-81. PubMed ID: 23443316 [TBL] [Abstract][Full Text] [Related]
7. SMAD4 endows TGF-β1-induced highly invasive tumor cells with ferroptosis vulnerability in pancreatic cancer. Chen HD; Ye Z; Hu HF; Fan GX; Hu YH; Li Z; Li BR; Ji SR; Zhou CJ; Xu XW; Yu XJ; Qin Y Acta Pharmacol Sin; 2024 Apr; 45(4):844-856. PubMed ID: 38057506 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802 [TBL] [Abstract][Full Text] [Related]
9. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1. Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861 [TBL] [Abstract][Full Text] [Related]
10. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584 [TBL] [Abstract][Full Text] [Related]
11. Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis. Leung L; Radulovich N; Zhu CQ; Wang D; To C; Ibrahimov E; Tsao MS PLoS One; 2013; 8(12):e84366. PubMed ID: 24386371 [TBL] [Abstract][Full Text] [Related]
12. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells. Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091 [TBL] [Abstract][Full Text] [Related]
13. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status. Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911 [TBL] [Abstract][Full Text] [Related]
14. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma. Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906 [TBL] [Abstract][Full Text] [Related]
15. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells. Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168 [TBL] [Abstract][Full Text] [Related]
16. Correlation between S100A11 and the TGF-β Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945 [TBL] [Abstract][Full Text] [Related]
17. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma. Dardare J; Witz A; Merlin JL; Gilson P; Harlé A Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429474 [TBL] [Abstract][Full Text] [Related]
18. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1. Basso D; Bozzato D; Padoan A; Moz S; Zambon CF; Fogar P; Greco E; Scorzeto M; Simonato F; Navaglia F; Fassan M; Pelloso M; Dupont S; Pedrazzoli S; Fassina A; Plebani M Cell Commun Signal; 2014 Mar; 12():20. PubMed ID: 24670043 [TBL] [Abstract][Full Text] [Related]
19. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes. Craven KE; Gore J; Wilson JL; Korc M Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478 [TBL] [Abstract][Full Text] [Related]
20. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells. Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]